Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
Authors:
- Mona A. OmarMOMona A. Omar
- Mohamed M. OmranMOMohamed M. Omran
- Khaled FaridKFKhaled Farid
- Ashraf A. TabllAshraf A. Tabll
- Yasser E. ShaheinYSYasser E. Shahein
- Tarek M. EmranTETarek M. Emran
- Ana PetrovicAPAna Petrovic
- Nikola R. LucicNLNikola R. Lucic
- Robert SmolicRSRobert Smolic
- Tanja KovacTKTanja Kovac
- Martina SmolicMSMartina Smolic
Open Access
- 28 June 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (7) , 1852
Abstract
The incidence of hepatocellular carcinoma (HCC) and HCC-related deaths has increased over the last few decades. There are several risk factors of HCC such as viral hepatitis (B, C), cirrhosis, tobacco and alcohol use, aflatoxin-contaminated food, pesticides, diabetes, obesity, nonalcoholic fatty liver disease (NAFLD), and metabolic and genetic diseases. Diagnosis of HCC is based on different methods such as imaging ultrasonography (US), multiphasic enhanced computed tomography (CT), magnetic resonance imaging (MRI), and several diagnostic biomarkers. In this review, we examine the epidemiology of HCC worldwide and in Egypt as well as risk factors associated with the development of HCC and, finally, provide the updated diagnostic biomarkers for the diagnosis of HCC, particularly in the early stages of HCC. Several biomarkers are considered to diagnose HCC, including downregulated or upregulated protein markers secreted during HCC development, circulating nucleic acids or cells, metabolites, and the promising, recently identified biomarkers based on quantitative proteomics through the isobaric tags for relative and absolute quantitation (iTRAQ). In addition, a diagnostic model used to improve the sensitivity of combined biomarkers for the diagnosis of early HCC is discussed.Keywords
This publication has 121 references indexed in Scilit:
- Annexin A2 is a discriminative serological candidate in early hepatocellular carcinomaCarcinogenesis, 2012
- Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinomaBMC Research Notes, 2012
- Biomarkers for Hepatocellular CarcinomaInternational Journal of Hepatology, 2012
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort studyBMJ Open, 2012
- Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinomaBMC Research Notes, 2010
- Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MSJournal of Cancer Research and Clinical Oncology, 2010
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysisBritish Journal of Cancer, 2009
- Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinomaMolecular Carcinogenesis, 2003
- Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: A new candidate for early diagnosis of hepatocellular carcinomaHepatology, 1996